Disorders of Sex Development
6 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Narrower: Adrenal Hyperplasia, Congenital 1, Sexual Infantilism 2
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Osilodrostat for adrenal hyperplasia, congenital | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Phentermine / Topiramate Extended Release Oral Capsule [Qsymia] for sexual infantilism | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo (for Syntocinon) + Oxytocin for sexual infantilism | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Proton beam radiation therapy + Surgical resection for disorders of sex development | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Proton beam radiation therapy + Surgical resection + PAZOPANIB + Doxorubicin + Ifosfamide for disorders of sex development | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Proton beam radiation therapy + Surgical resection + SELINEXOR + PAZOPANIB + Doxorubicin + Ifosfamide for disorders of sex development | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.